Health Care & Life Sciences » Pharmaceuticals | Ilsung Pharmaceutical Co. Ltd.

Ilsung Pharmaceutical Co. Ltd.

Ilsung Pharmaceutical Co. Ltd.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW1123.98
Market Cap
KRW120 B
Shares Outstanding
2.66 M
Public Float
490 K

Profile

Address
9 Wonhyo-ro 84-gil
Seoul SL 04315
Korea, Republic Of
Employees -
Website http://www.ilsung-ph.co.kr
Updated 07/08/2019
Ilsung Pharmaceutical Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. Its products include contrast media, patches, antibiotics, antiviral agents, dermatologic agents, cardiovascular agents, antidiabetic agents, analgesics, muscle relaxants, neuropsychiatric agents, antitussives and expectorants. The company was founded by Yoon Byung-Kang in 1954 and is headquartered in Seoul, South Korea.

Financials

View All
Created with Highcharts 5.0.14Ilsung Pharmaceutical Co. Ltd.Net Income. Fiscal year is January-December. All values KRW Millions.7 9557 9554 0354 03598 85498 8543 0173 0172 6292 6292 9462 946201320142015201620172018025k50k75k100k125k
Created with Highcharts 5.0.14Ilsung Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.62 80762 80762 82962 82961 74561 74567 46367 46367 04367 04361 65361 653201320142015201620172018020k40k60k80k

Byun-Kang Yoon
Chairman
Suk-Keun Yoon
Chief Executive Officer & Director